Interaction between Paracoccidioides brasiliensis conidia and the coagulation system: involvement of fibrinogen

Diana Tamayo1, Orville Hernández, Cesar Muñoz-Cadavid

  • 1Molecular and Cell Biology Unit, Corporación para Investigaciones Biológicas, Medellín, Colombia.

Insights

Paracoccidioides brasiliensis conidia aggregate with human plasma proteins, influencing blood coagulation. This interaction may impact the initial inflammatory response and fungal disease progression.

Area of Science:

  • Mycology
  • Immunology
  • Hematology

Background:

  • The infectious process begins with pathogen-host contact.
  • Paracoccidioides brasiliensis conidia interact with plasma proteins like fibrinogen.
  • Fibrinogen is a key component of the blood coagulation system.

Purpose of the Study:

  • To evaluate the in vitro aggregation of P. brasiliensis conidia with plasma proteins and coagulation factors.
  • To assess the impact of various compounds on this aggregation process.
  • To determine the effect of conidial interaction on blood coagulation pathways.

Main Methods:

  • Incubation of P. brasiliensis conidia with human serum or plasma.
  • Testing aggregation with extracellular matrix (ECM) proteins, monosaccharides, anticoagulants, and inhibitors.
  • Measurement of prothrombin time and partial thromboplastin time.
  • Assessing alterations in coagulation pathways (extrinsic and intrinsic).

Main Results:

  • Extracellular matrix proteins, monosaccharides, and human plasma significantly induced conidial aggregation.
  • Anticoagulants and metabolic/protein inhibitors reduced conidial aggregation.
  • The extrinsic coagulation pathway remained unaffected, while the intrinsic pathway was significantly altered.

Conclusions:

  • P. brasiliensis conidia interact with proteins of the blood coagulation system.
  • This interaction influences the intrinsic coagulation pathway.
  • The findings suggest a role for coagulation protein interaction in the initial inflammatory response and fungal disease dissemination.

Related Concept Videos

Coagulation01:06

Coagulation

Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Complement System01:27

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...